Researcher
Mark De Ridder
- Research Expertise:
- Clinical Oncology and Radiation Oncology
- Radiobiology
- Molecular Biology
- Keywords:Medicine
- Disciplines:Radiation therapy
- Users of research expertise:
- Clinical Oncology and Radiation Oncology
- Radiobiology
- Molecular Biology
Affiliations
- Radiation Therapy (Department)
Member
From1 Jul 2013 → Today - Translational Radiation Oncology and Physics (Research group)
Responsible
From20 Oct 2010 → Today - Clinical sciences (Department)
Member
From1 Feb 2023 → Today - Clinical sciences (Department)
Member
From1 Jan 2023 → Today - Clinical sciences (Department)
Member
From1 Oct 2019 → 31 Jan 2023 - Clinical sciences (Department)
Member
From8 Apr 2019 → 31 Dec 2022 - Faculty of Medicine and Pharmacy (Faculty)
Member
From22 Jun 2017 → 7 Sep 2017 - Clinical sciences (Department)
Responsible
From1 Jan 2014 → 20 Oct 2022 - Medical Imaging and Physical Sciences (Department)
Member
From1 Mar 2010 → 31 Dec 2013 - Radiation Therapy (Department)
Member
From1 Jan 2008 → 31 Dec 2011 - Medical Imaging and Physical Sciences (Department)
Member
From1 Oct 2001 → 30 Sep 2011
Projects
1 - 5 of 5
- RESTORE: REalistic forecaSTing, cOntrol and pREparedness for coming COVID-19 wavesFrom22 May 2020 → 21 May 2021Funding: FWO research project (including WEAVE projects)
- Uncovering the daily experiences of people with advanced cancer: adaptation and feasibility of the experience sampling methodFrom1 Jan 2020 → 31 Dec 2023Funding: FWO research project (including WEAVE projects)
- SRP-Onderzoekszwaartepunt: Societal Benefit of Markerless Stereotactic Body Radiotherapy: a Statistical Support based on Quantitative ImagingFrom1 Mar 2019 → 29 Feb 2024Funding: BOF - projects
- SRP (Groeiers): Translating biological tumor signatures into image-guided radiotherapy: towards personalized treatments in rectal and lung cancerFrom1 Mar 2014 → 28 Feb 2019Funding: BOF - Concerted Research Project from 1994
- Tumor Radiosensitization by Expanded T lymphocytes: NO and CO as Molecular Determinants of Radioresponse through the IFN-γ Signalling PathwayFrom1 Jan 2010 → 31 Dec 2013Funding: FWO research project (including WEAVE projects)
Publications
11 - 20 of 140
- Breast radiotherapy for non-low-risk ductal carcinoma in situ(2023)
Authors: Thomas Mulliez, Mark De Ridder
Pages: 23-24 - Interpretability and Repeatability of Radiomic Features: Applied on In Vivo Tumor Models(2023)
Authors: Amir Laraki Rifi, Inès Dufait, Chaïmae El Aisati, Mark De Ridder, Kurt Barbé
Pages: 1-1 - Colorectal Cancer Immunotherapy: State of the Art and Future Directions(2023)
Authors: Alyssa Mauri Cornista, Maria Virginia Giolito, Kristi Baker, Hajar Hazime, Inès Dufait, Jashodeep Datta, Saratchandra Singh Khumukcham, Mark De Ridder, Jatin Roper, Maria T. Abreu, et al.
Pages: 1103-1119 - Lung-Heart Outcomes and Mortality through the 2020 COVID-19 Pandemic in a Prospective Cohort of Breast Cancer Radiotherapy Patients(2022)
Authors: Vincent Vinh-Hung, Olena Gorobets, Nele Adriaenssens, Hilde Van Parijs, Guy Storme, Dirk Verellen, Nam P Nguyen, Nicolas Magne, Mark De Ridder
- Inhibition of Phosphoglycerate Dehydrogenase Radiosensitizes Human Colorectal Cancer Cells under Hypoxic Conditions(2022)
Authors: Melissa Van De Gucht, Inès Dufait, Lisa Kerkhove, Cyril Corbet, Sven Luk De Mey, Heng Jiang, Lun Law Ka, Thierry Gevaert, Olivier Feron, Mark De Ridder
- Pre-OPerative Accelerated breast Radio Therapy (POPART)(2022)
Authors: Thomas Mulliez, Mark De Ridder
Pages: 170-170 - Lung Restriction in Patients With Breast Cancer After Hypofractionated and Conventional Radiation Therapy(2022)
Authors: Sylvia Verbanck, Hilde Van Parijs, Daniel Schuermans, Vincent Vinh-Hung, Guy Storme, Christel Fontaine, Mark De Ridder, Dirk Verellen, Eef Vanderhelst, Shane Hanon
Pages: 561-569 - Pre-OPerative accelerated radiotherapy for early stage breast cancer patients (POPART)(2022)
Authors: Thomas Mulliez, Geertje Miedema, Hilde Van Parijs, Nathalie Hottat, Maud Vassilieff, Evy Gillet, Luc Baeyens, Mia Voordeckers, Jolien Marguerite Coelmont, Tatiana Besse-Hammer, et al.
Pages: 118-121 - Is there utility for fluorine-18-fluorodeoxyglucose positron-emission tomography scan before surgery in breast cancer?(2022)
Authors: Justine Perrin, Karim Farid, Hilde Van Parijs, Olena Gorobets, Vincent Vinh-Hung, Nam P Nguyen, Navid Djassemi, Mark De Ridder, Hendrik Everaert
Pages: 287-302 - Quantifying Societal Burden of Radiation-Induced Cardiovascular Events in Breast Cancer Survivors(2022)
Authors: Eva Kimpe, Amber Werbrouck, Mark De Ridder, Koen Putman
Pages: 1-11